FDA Investigator Lauren E Swantko

Lauren E Swantko has conducted inspections on 165 sites in 9 countries as of 20 Aug 2018. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
165
Last Inspection Date:
20 Aug 2018
Investigator Role:
FDA Investigator
Redica ID:
100003434
Countries of Inspections:
United States of America, India, Ukraine, Canada, United Kingdom of Great Britain and Northern Ireland, Ireland, Poland, Italy, Serbia
FDA Investigators that have inspected at least one site in common with Lauren E Swantko:
Aaron J Poloni, Abigail A Andersen, Alan D Grupe, Aleta T Flores, Alexander M Kay, Alicia Aborg Borm, Anita Narula, PhD, Anthony E Keller, RPh, Arie R Dyk, Ava M Bowman, Barbara Janine Breithaupt, Belinda E Clifton, Beverly A Thomas, Brenda K Alford, Bruce R Burrell, Bryan Baker, Bryce E Mansfield, Celeta S Coves, Celia L Hutchinstein, Celia L Silverstein, Christina L Norton, Christopher R Czajka, Clint R Van Blaricom, Connie P Rezendes, Dan G Eisenbrey, Dawn E Barkans, Deborah Kleinfeld, Dennis G Kawabata, Dennis M Farley, Dennis R Hudson, Diane Hall, Dianna D Wardlow Dotter, Dianne B Latona, Dipti Kalra, Dolores E Price, Don A Leeseberg, Donald W Jehn, Dustin P Tran, Elizabeth E Hart (ASCP), MT, Elizabeth S Howell, Emily B Camire, Eric C Milstead, Eric L Scott, Eric T Huebler, Farhana Khan, Gabriel M Guevarra, Garrad R Poole, Gavin W Pierce, Gerard Pde Leon, Gina C Collins, Gloria A Milster, Gloria J Baca, MS, Haley H Seymour, Harmon M Blanch, Herbert E Arden, Hugh A Grimoldby, Hugh M Mcclure, II, Jacob N Hamilton, James A Lane, James D Hildreth, James H Robinson, Jean Brewer, Jeanne M Weishaar, Jeffrey J Leclair, Jessica B Clark, Jessica L Walters Moell, Jessie J Deloach, Jinkee Mvila Binayug, John A Iwen, John W Banks, Jonathan T Little, Joseph A Seitz, III, Julian C Hanson, Ka L Wong, Kaarin M Slotte, Kaitlyn R Kornberg, Karen M Montgomery (KMM), Katherine L Arnold, Kathryn A Krentz, Kellie L Westerbuhr, Kelsey A Hustedt, Kimberly Jproctor Jones, Kip J Hanks, Lakecha N Lewis, Lance Mde Souza, MBA, Lance W Bohm, Laurissa S Flowers, Laverne Puckett, Lawrence Y Lee, PhD, LCDR Ismael Olvera, IV, LCDR Margaret Edi Gennaro, Lee Terry Moore, Lesley A Swanson, Lester O Boian, Leya A Grosch, Lisa K Capron, Lisa M Althar, Lori J Silverstein, LTJG Bradley E Benasutti, Maida Henesian (NMI), Marc A Jackson, Jr, Marcus A Goshen, Margo C Jones, Maria Pkelly Doggett, MBA, Mark E Imsland, Mark W Babbitt, Marlene L Davis, Mary Ewilkerson Brinsko, Mary T Carden, Matthew J Gretkierewicz, Melissa D Kalik, Michael F Schuette, Michael I Gorman, Michael J Donovan, Michael S Hudson, Minh D Phan, Narahi J Alvarez Alcazar, Neil J Traaen, Paul M Chefor, Peter Kessler, PhD, Peter T Regan, Rachel J Cantrell, Randy L Elsberry, Raymond W Brullo, Rebecca A Sletner, Rebecca T Davis, Richard J Bashay, Richard T Riggie, Robert A Williams, Robert S Sweeton, Rocco C Black, Roger J Adams, S Lori Brown, PhD MPH, Sandra S Saniga, Scott Reynolds, Shannon J Hall, Shelagh D Schopen, Shelley H Beausoleil, Shelley H Roberts, Sherri N Rohlf, MD, Stacy A Schneider, Stephanie A Slater, MS, Stephen R Souza, Stephen T Hansen, Stuart W Russell, Sunitha K Rajaram, PhD, Sunny R Muir, Tania Y Hall, Thomas C Mclean, CFS, Timothy P Lafave, Travis S Bradley, Vanessa Y Gelsey, PhD, Vanessa Y Jacobs, Veronica L Bush, Vitaliy N Guyvan, William A Burkey, William J Foust, Young M Yoon, Yvonne C Wilkes, Zachary P Wachlarowicz

Lauren E Swantko's Documents

Publish Date Document Type Title
July, 2012 EIR Xtant Medical Holdings Inc - EIR, 2012-07-26
April, 2012 FDA 483 Response Biomat USA, Inc. - Form 483R, 2012-05-09
July, 2015 FDA 483 David A. Evans, M.D. - Form 483, 2015-07-22
January, 2013 EIR Boise VAMC - EIR, 2013-01-24
January, 2013 FDA 483 Boise VAMC - Form 483, 2013-01-24
July, 2012 FDA 483 Xtant Medical Holdings Inc - Form 483, 2012-07-26
July, 2018 FDA 483 Olukemi Wallace - Form 483, 2018-07-13
July, 2015 EIR David A. Evans, M.D. - EIR, 2015-07-22

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more